Search company, investor...

About Yaohua

Yaohua manufactures glass products. The company researches, develops, produces, processes, and markets flat glass, processed glass, glass marble, resins, and other related products. It is based in Qinhuangdao, Hebei.

Headquarters Location

No. 61, Xigang North Road

Qinhuangdao, Hebei, 066002,




Latest Yaohua News

Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation

Mar 15, 2023

03/15/2023 | 09:06am EDT Message : *Required fields Guided Therapeutics, Inc. (the “Company”) (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, announced today that it had signed a new agreement (the “Agreement”) with the Company’s Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument Corporation (“SMI”). This Agreement supersedes the agreement between the Company and SMI previously signed on August 21, 2021. The Agreement includes two purchase orders from SMI, one previously entered into on December 3, 2018, which has been amended in full, and a new purchase order which was entered into in March 2023 totaling a minimum of $3,931,600 for goods and services from the Company, including device components, license payments, and technical expertise. In the first full calendar year following approval by the National Medical Products Administration (the “NMPA”, formerly the China Food and Drug Administration), SMI will be committed to purchase from the Company, at minimum, license fees and component purchases of approximately $40 million over a four-year period. SMI has informed the Company that it expects to complete the clinical trial required to obtain NMPA approval by the middle of this year. Further, SMI expects to receive final regulatory approval to market in China by the end of this year. Under the Agreement, approximately $2.1 million of the purchase orders must be fulfilled by the time SMI files its application with clinical data to the NMPA. Approximately $570,000 is due at the time NMPA approval is obtained, and another $1.24 million is due by March 31, 2024. SMI has an option to purchase an additional $1.24 million worth of single use components by October 31, 2024. These purchase orders, especially those involving single use components, are fueled by SMI’s ongoing negotiations involving government sponsored cervical cancer screening programs using LuViva’s novel biophotonic technology. “We are pleased that the clinical trials are going well, no longer impacted by Covid-19 lockdowns and back on track, the result of which are increased orders from China. These orders are expected to result in a significant increase in sales revenue not only for this year, but also for many years to come,” said Mark Faupel, Chief Executive Officer of Guided Therapeutics. “We are gearing up to supply SMI with the parts and expertise it needs to be successful in the Chinese market.” About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company’s first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: . The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and “Early detection, better outcomes” are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics’ actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading “Risk Factors” in Guided Therapeutics’ reports filed with the SEC, including Guided Therapeutics’ Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and subsequent filings. View source version on © Business Wire 2023

Yaohua Frequently Asked Questions (FAQ)

  • Where is Yaohua's headquarters?

    Yaohua's headquarters is located at No. 61, Xigang North Road, Qinhuangdao.

  • Who are Yaohua's competitors?

    Competitors of Yaohua include Beihua Gaoke and 4 more.


Compare Yaohua to Competitors

China Yaohua Glass Group

China Yaohua Glass Group is a glass manufacturer. Its main products are quality float glass, auto glass, architectural energy efficent glass, and tinted glass. It is based in Qinhuangdao, Hebei.

Lingbao Shenghe Optical Glass Materials

Lingbao Shenghe Optical Glass Materials is a technology entity engaged in the research, development, production, and sales of new optical glass materials. The company produces and processes a variety of optical glass material additives, including rare earth precision molding materials, fluorophosphate and fluoride glass materials, and other optical glass additives. They also produce and extract valuable substances from their mining resources, selling raw mineral substances with an annual sales volume of 80,000 to 100,000 tons. It was founded in 2004 and is based in Lingbao, Henan.


Sinoquartz is engaged in the R&D, production, and sales of fused silica glass materials. It is the R&D and manufacturing base of core optical materials for large-scale optical engineering in the country. The company was founded in 2012 and is based in Mianyang, China.

Sunking Precision

Sunking Precision is a target research and development company. The company focuses on domestic CT machine anode target discs, glass-based optical element molding materials, and diamond-copper high thermal conductivity electronics. The company provides common technology research and development and a production platform for spark plasma sintering. The company was founded in 2021 and is based in Hefei, China.


AGC (TYO: 5201) operates as a company focusing on the production and supply of materials and components, operating within the glass, automotive, display glass, chemicals, ceramics, and electronics sectors. The company's main offerings include flat glass, automotive glass, display glass, chemicals, ceramics, and other materials. It primarily serves the automotive and building industries, being a global leader in both sectors. AGC was formerly known as Asahi Glass Company. The company was founded in 1907 and is based in Tokyo, Japan.

China Glass Holdings

China Glass Holdings specializes in glass manufacturing and technology services within the materials industry. The company offers a range of glass products including high-transparency glass, high-white glass, body-tinted glass, colorless transparent glass, and various energy-saving and low-emissivity coated glass products. These products cater to the construction, automotive, and solar energy sectors. It is based in Beijing, Beijing.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.